Antimicrobial Peptide Derivatives for Membrane Disruption
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing antimicrobial peptides (AMPs) have weak antimicrobial activity, are unstable, and lack broad-spectrum antimicrobial activity, making them ineffective against various microorganisms and cancer cells.
Innovation Solution
Development of a peptide derivative with specific amino acid sequences that can combine with cell membranes to destroy microbial and cancer cell membranes, incorporating modifications such as cyclic bonds and unnatural amino acids to enhance stability and activity, and preparation of a composition with a pharmaceutically acceptable carrier for broad applications.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional antibiotics are used to treat acne caused by P. acnes, then initial treatment efficacy is achieved, but antibiotic resistance develops quickly
Solution Approach 1:
The patent changes the chemical structure parameters of peptide molecules by introducing D-amino acids, cyclic bonds, and specific amino acid sequences to create antimicrobial peptides with novel structures that microorganisms have not developed resistance against, while maintaining effective antimicrobial activity
Solution Approach 2:
The patent creates composite antimicrobial peptide structures combining multiple amino acid types (D-amino acids, cyclic bonds, disulfide bridges) to produce peptides with enhanced stability and antimicrobial activity that overcome traditional antibiotic resistance mechanisms
2Reliability
If high concentration of benzoyl peroxide or dapsone gel is used to treat acne, then antimicrobial efficacy improves, but toxic side effects increase greatly
Solution Approach 1:
The patent optimizes the molecular parameters of antimicrobial peptides including amino acid composition, chain length, and structural configuration to achieve maximum antimicrobial efficacy at low concentrations while minimizing cytotoxicity to human cells
Solution Approach 2:
The patent introduces D-amino acids at specific positions within the peptide sequence to enhance antimicrobial activity locally at the target site while the overall peptide structure maintains biocompatibility and reduced systemic toxicity
3Reliability
If plant AMPs are used for antimicrobial activity, then initial antimicrobial effect is achieved, but stability decreases due to easy hydrolysis by proteolytic enzymes
Solution Approach 1:
The patent changes the chemical parameters of peptide bonds by incorporating D-amino acids and forming cyclic structures with disulfide bridges, which resist proteolytic enzyme hydrolysis while preserving antimicrobial activity
Solution Approach 2:
The patent introduces cyclic bonds and disulfide bridges that create three-dimensional folded structures in the peptide chain, making the peptide backbone less accessible to proteolytic enzymes and significantly improving stability
4Reliability
If existing AMPs are used for treatment, then some antimicrobial activity is achieved, but broad-spectrum antimicrobial activity is lacking
Solution Approach 1:
The patent designs antimicrobial peptides with universal structural features including D-amino acid residues, cyclic bonds, and amphipathic structures that enable effective interaction with diverse microbial cell membranes across different pathogen types, achieving broad-spectrum activity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The peptide derivative exhibits strong antimicrobial and antitumor activity, stability against peptidase degradation, and broad-spectrum efficacy, suitable for use in various applications including packaging, medical supplies, and disinfectants, reducing microbial growth and cancer cell proliferation.
Implementation Method 1
The peptide derivative exhibits strong antimicrobial and antitumor activity, stability against peptidase degradation
Data Source
AI summary
An antimicrobial peptide (AMP) or peptide derivative, a substitute for the AMP or peptide derivative, an AMP or peptide derivative composition, and a preparation method and application of the AMP or peptide derivative composition. The AMP or peptide derivative includes at least one selected from the group consisting of amino acid sequences I and II:where Xa1, Ba1, U1, Za1, Ba2, Xa2, Ba3, Za2, Ba4, Xa3, Xb1, Bb1, Ca1, Zb1, Bb2, Xb2, Bb3, Zb2, Bb4, Xb3, and Ca2 each are independently selected from the group consisting of natural amino acids (NAAs) and unnatural amino acids (UAAs). The AMP or peptide derivative provided by the present application can combine with a lipid structure of a cell wall/membrane to damage its physical and chemical properties, thereby destroying the microbial wall/membrane to kill microorganisms and tumor cells.